Sensus Healthcare, Inc.

Sensus Healthcare, Inc. Earnings Recaps

SRTS Health Care 2 recaps
Q1 2026 May 8, 2026

Sensus Healthcare’s shares plunged 24.7% after earnings, driven by cautious outlook signals and execution risks around the transition to the new CPT code environment, despite management’s positive framing of increasing adoption and pipeline development.

Key takeaways
  • The company highlighted a pivotal transition to new CPT codes for superficial radiotherapy and is focused on educating the market and driving adoption.
  • Reported shipments included 14 SRT systems with progress in diversifying the customer base and reducing historical customer concentration, matching Q4 levels.
  • Treatment volumes increased 8% year-over-year, supported by 18 active FDA sites and 9 pending activations, fueling recurring revenue streams estimated at ~10% of total revenue.
  • Launched new financial services and SensusLink software to drive recurring revenue, aiming to shift customer preferences from rental agreements to purchases.
  • Despite these initiatives, investors reacted negatively, likely signaling disappointment in either the pace of execution, deceleration risks, or concerns over profitability and sustainable margin improvement amid ongoing market uncertainty.
Full recap
Q3 2025 Nov 7, 2025

Sensus Healthcare's Q3 2025 performance showcases significant advancements, including the introduction of new CPT codes for superficial radiotherapy, which are expected to drive increased demand and enhanced reimbursement.

Key takeaways
  • CMS has established new dedicated CPT codes for superficial radiotherapy, promising over 300% reimbursement increases per treatment fraction.
  • The company recorded a 20% growth in FDA treatment volumes from Q2, marking the third consecutive quarter of double-digit growth; total treatments rose 157% since the program's launch.
  • Sensus shipped 16 SRT systems in Q3, reaching over 900 systems sold globally, with an expectation to hit 1,000 by 2026.
  • Strong cash position increased to $24.5 million, aided by improved working capital management, positioning the company to meet anticipated demand.
Full recap